10.24335/L27680
RoyaltyStat
Exclusive patent, process and know-how license to develop, make, use, sell, offer, import, export and sublicense devices and products for the delivery of drugs through injection by means of needle-free technology, including delivery of insulin, exendin, GLP and MC-4 agonist compounds to diagnose, treat or prevent diabetes, obesity or other uses, including the MJ7 and MJ8 variable dosage devices.
RoyaltyStat
2003